Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry.

As the State relinquishes its role as coordinator of interorganizational asset transfers, how do interdendent suppliers and users of complementary assets find each other and manage transactions for these assets? This study compares the emerging market structure of two different types of complementary assets in the pharmaceutical industry - new product technology (R&D) and sales and distribution (Wholesaling).

MoreLess

Year of publication:	1997-09
Authors:	White, Steven ; Liu, Xielin
Institutions:	Research Institute for Economics and Business Administration, Kobe University
Subject:	Pharmaceutical industry \| Financial market

More details

Series:	Discussion Paper Series. - ISSN 1345-2207.
Type of publication:	Book / Working Paper
Notes:	Number 83 29 pages
Classification:	L65 - Chemicals; Rubber; Drugs; Biotechnology ; D23 - Organizational Behavior; Transaction Costs; Property Rights
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10005784020